Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Diathermy × Sarcoma × Clear all

Phase

Status

Completed 4 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2 Gastrointestinal 2 Breast 2 Sarcoma 1 Head & Neck 1 Genitourinary 1

Conditions

Hemorrhage 1 Bone Neoplasms 1

Interventions

Cyclophosphamide 24 Temozolomide 22 Doxorubicin 21 Radiotherapy 18 Filgrastim 16 Ifosfamide 13 Etoposide 13 Gemcitabine 12 Cisplatin 12 pazopanib 11 Irinotecan 11 Imatinib Mesylate 11 Bevacizumab 11 Carboplatin 10 Magnetic Resonance Spectroscopy 9 Granulocyte Colony-Stimulating Factor 9 Rituximab 8 Radiation 8 Docetaxel 8 Cyclosporine 8 pembrolizumab 7 fludarabine phosphate 7 Vincristine 7 Methotrexate 7 Melphalan 7 Dexrazoxane 7 Busulfan 7 Antilymphocyte Serum 7 fludarabine 6 Radiotherapy, Intensity-Modulated 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡